Defective killing activity against gp120/41-expressing human erythroleukaemic K562 cell line by monocytes and natural killer cells from HIV-infected individuals

AIDS

Volumn 10, Issue 2, 1996, Pages 143-149

  Ahmad, Ali ^a   Menezes, José ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

AIDS; gp120 gp41; HIV 1; Monocytes; Natural killer activity

Indexed keywords

CD4 ANTIGEN; CHROMIUM 51; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41;

ARTICLE; CELL KILLING; CELL MEDIATED CYTOTOXICITY; CELL STRAIN K 562; EFFECTOR CELL; ENVELOPE GENE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONOCYTE; NATURAL KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL; TARGET CELL; VIRUS GENE;

EID: 0030059501     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199602000-00003     Document Type: Article

References (40)

1. Barre-Sinoussi F, Cherman JC, Rey F, et al.: Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immunodeficiency syndrome (AIDS). Science 1983, 220:808-870.
2. Levy JA, Hoffman AD, Kramer SM, Landis JA, Shimabukuro JM, Oshiro US: Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science 1984, 225:840-842.
3. Popovic M, Sarangadharan MG, Read E, Gallo RC: Detection, isolation and continuous production of cytopathic retroviruses (HTLV-III) form patients with AIDS and pre-AIDS. Science 1984, 224:1684-1686.
4. Fahey JL, Prince H, Weaver M, et al.: Quantitative changes in T helper or T suppressor/cytotoxic lymphocyte subsets that distinguish acquired immunodeficiency syndrome from other immune subset disorders. Am J Med 1984, 96:693-700.
5. Bowen DL, Lane HC, Fauci AS: Immunopathogenesis of the acquired immunodeficiency syndrome. Ann Intern Med 1985, 103:704-711.
6. Seligmann M, Pinching AJ, Rosen FS, et al.: Immunology of human immunodeficiency virus infection and the acquired immunodeficiency syndrome: an update. Ann Intern Med 1987, 107:234-242.
7. Lifson JD, Feinberg MB, Reys GR, et al.: Induction of CD4-dependent cell fusion by the HTLVIII/LAV envelope glycoproteins. Nature 1986, 323:725-728.
8. Sodroski J, Goh WC, Rosen C, Campbell K, Haseltine WA: Role of HTLVIII/LAV envelope in syncytium formation and cytopathicity. Nature 1986, 322:470-474.
9. Hoxie JLA, Alpers JD, Rackowski J, et al.: Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV. Science 1986, 234:1123-1127.
10. Stevenson M, Meier C, Mann AM, Chapman N, Wasiak A: Envelope glycoprotein of HIV induces interference and cytolysis resistance in CD4+ cells: mechanism for persistence in AIDS. Cell 1988, 53:483-496.
11. Hoffman GE, Kion TA, Grant MD: An idiotypic network model of AIDS pathogenesis. Proc Natl Acad Sci USA 1991, 88:3060-3064.
12. Laurence J, Hodtsev AS, Posnett DN: Superantigen implicated in dependence of HIV-1 replication in T cells on TCR Vβ expression. Nature 1992, 358:255-259.
13. Meyaard L, Otto SA, Jonker RR, Mijnster MJ, Keet RPM, Miedema F: Programmed death of T cells in HIV-1 infection. Science 1992, 257:217-219.
14. Dalgleish AG, Beverley PCL, Clapham PR, Crawford DH, Greaves MF, Weiss RA: The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1984, 312:763-767.
15. Klatzmann D, Champagne E, Chamaret S, et al.: T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 1984, 312:767-768.
16. Shioda T, Levy JA, Cheng-Meyer C: Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene. Nature 1991, 349:167-169.
17. Berman PW, Riddle L, Nakamura G, et al.: Expression and immunogenicity of the extracellular domain of the human immunodeficiency virus type 1 envelope glycoprotein, gp160. J Virol 1989, 63:3489-3498.
18. Berman PW, Gregory T, Riddle L, et al.: Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp160. Nature 1990, 345:622-625.
19. Hu SL, Abrams K, Barber GN, et al.: Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160. Science 1992, 255:456-459.
20. Rappocciolo G, Toso JF, Torpy DJ, Gupta P, Rinaldo CR: Association of alpha interferon production with natural killer cell lysis of U937 cells infected with human immunodeficiency virus. J Clin Microbiol 1989, 27:41-48.
21. Sirianni MC, Taliaferri F, Aiuti F: Pathogenesis of the natural killer cell deficiency in AIDS. Immunol Today 1990, 11:81-82.
22. Ahmad A, Ladha A, Cohen E, Menezes J: Stable expression of the transfected HIV-1 gene in a human B cell line: characterization of gp120-expressing clones and immunobiological studies. Virology 1993, 192:447-457.
23. Lozzio CB, Lozzio BB: Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome. Blood 1977, 45:321-328.
24. Kundu SK, Menezes J: Interleukin-2 induced killer cell activity against Epstein-Barr virus-immortalized human B cells. Immunol Lett 1989, 20:299-304.
25. Khyatti M, Patel PC, Stefanescu I, Menezes J: Epstein-Barr virus (EBV) glycoprotein gp350 expressed on transfected cells resistant of natural killer cell activity serves as a target antigen for EBV-specific antibody-dependent cellular cytotoxicity. J Virol 1991, 65:996-1001.
26. Pross HF, Callewaert D, Rubin P: Assays for NK cell cytotoxicity - their values and pitfalls. In Immunobiology of Natural Killer Cells, vol 1. Edited by Lotzova E. Boca Raton: CRC Press; 1986:1.
27. Malkovsky M, Philpott K, Dalgleish AG, et al.: Infection of B lymphocytes by the human immunodeficiency virus and their susceptibility to cytotoxic cells. Eur J Immunol 1988, 18:1315-1321.
28. Rola-Pleszczynski M, Bolduc D, St-Pierre S: The effect of vasoactive intestinal paptide on human natural killer cell function. J Immunol 1985, 135:2569-2573.
29. Debs RJ, Krowka J, Stites D, Brunette EN, Duzgunes N, Philip R: Monocyte-mediated lysis of HIV-infected tumor cells. AIDS Res Hum Retroviruses 1990, 6:1005-1009.
30. Meltzer MS, Skillman DR, Hoover DL, et al.: Macrophages and the human immunodeficiency virus. Immunol Today 1990, 11:217-223.
31. Kawamura I, Koga Y, Oh-Hori N, Onodera K, Dimura G, Nomolo KI: Depletion of surface CD4 molecule by the envelope protein of human immunodeficiency virus expressed in a human CD4-positive monocytoid cell line. J Virol 1989, 63:3748-3754.
32. Wright SC, Jewett A, Mitsuyasu R, Bonavida B: Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients. J Immunol 1988, 141:99-104.
33. Munker R, Koeffler P: In vitro action of tumor necrosis factor on myeloid leukemic cells. Blood 1987, 69:1102-1108.
34. Tyler DS, Nastala CL, Stanley SD, et al.: gp120-specific cellular cytotoxicity in HIV-seropositive individuals: evidence for circulating CD16+ effector cells armed in vivo with cytophilic antibodies. J Immunol 1989, 142:1177-1182.
35. Ahmad A, Morisset R, Thomas R, Menezes J: Evidence for a defect of antibody dependent cellular cytotoxic (ADCC) and anti-HIV gp120/41-specific ADCC-mediating antibody titres in HIV-infected individuals. J Acquir Immune Defic Syndr 1994, 7:428-437.
36. Poli G, Introna M, Zanaboni F, et al.: Natural killer cells in intravenous drug abusers with lymphadenopathy syndrome. Clin Exp Immunol 1985, 62:128-135.
37. Sirianni MC, Soddus S, Malorni W, Aiancia G, Aiuti F: Mechanism of defective natural killer activity in patients with AIDS is associated with defective distribution of tubulin. J Immunol 1988, 140:2565.
38. Ullum H, Gotzsche PC, Victor J, Dickmeiss E, Skinhoj P, Pederson BK: Defective natural immunity: An early manifestation of human immunodeficiency virus infection. J Exp Med 1995, 182:789-799.
39. Marshall PS, Spina CA, Giorgi JV, et al.: Alterations in cytotoxic and phenotypic subsets of natural killer cells in acquired immune deficiency syndrome (AIDS). J Clin Immunol 1987, 7:16-24.
40. Vuillier F, Bianco NE, Montagnier L, Dighiero G: Selective depletion of low density CD8+, CD16+ lymphocytes during HIV infection. AIDS Res Hum Retroviruses 1988, 4:121-129.